Parkinsonian Disorders Clinical Trial
Official title:
Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies: the Model of an Oral Glucose Load
Excessive daytime sleepiness (EDS) is observed in 30 to 50 % of patients with Parkinson's disease (PD) patients, Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA). It is a major complain and represents a socially relevant problem as unintended episodes of sleep can also occur while driving for example. Arterial hypotension is frequently observed in patients with PD, DLB and MSA and considered as a marker of autonomic failure. Sleepiness is known to occur preferentially when patients are having arterial hypotension whatever the cause (i.e. postprandial period, administration of hypotensive medication such as dopamine agonists). We hypothesize that arterial hypotension is associated with abnormal sleepiness. We have observed this association in an on-going epidemiological survey Hyperglycaemia induced by oral glucose load - a standardized model simulating food intake during a meal - provokes arterial hypotension in the majority of Parkinson's disease patients with dysautonomia. It can be hypothesised that sleep attacks in these patients could be mediated by this fall in blood pressure.
Excessive daytime sleepiness (EDS) is observed in 30 to 50 % of patients with Parkinson's disease (PD) patients, Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA). It is a major complain and represents a socially relevant problem as unintended episodes of sleep can also occur while driving for example. The exact pathophysiology of EDS in PD, DLB and MSA has not been fully elucidated so far, although pharmacological factors (dopaminergic medications) and pathological factors (neurodegeneration of sleep-wakefulness regulatory areas) have been identified. Arterial hypotension is frequently observed in patients with PD, DLB and MSA and considered as a marker of autonomic failure. Sleepiness is known to occur preferentially when patients are having arterial hypotension whatever the cause (i.e. postprandial period, administration of hypotensive medication such as dopamine agonists). We hypothesize that arterial hypotension is associated with abnormal sleepiness. We have observed this association in an on-going epidemiological survey (COPARK Cohort of 800 PD patients, manuscript in preparation). Hyperglycaemia induced by oral glucose load - a standardized model simulating food intake during a meal - provokes arterial hypotension in the majority of Parkinson's disease patients with dysautonomia. It can be hypothesised that sleep attacks in these patients could be mediated by this fall in blood pressure. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT04704349 -
Latest Imaging SPECT System Evaluation Phase 1
|
N/A | |
Recruiting |
NCT03649503 -
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
|
||
Completed |
NCT01385592 -
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
|
Phase 2 | |
Completed |
NCT05608915 -
External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
|
N/A | |
Recruiting |
NCT04871464 -
Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
|
Phase 4 | |
Withdrawn |
NCT04847609 -
GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders
|
||
Completed |
NCT05356845 -
Oral Health, Orofacial Function and Oral Health Care in Patients With Parkinson's Disease
|
||
Completed |
NCT03065192 -
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
|
Phase 1 | |
Not yet recruiting |
NCT04727658 -
Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL)
|
Phase 2 | |
Recruiting |
NCT02696603 -
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
|
N/A | |
Completed |
NCT01491932 -
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
|
Phase 2 | |
Recruiting |
NCT05906719 -
Machine Vision Based MDS-UPDRS III Machine Rating
|
||
Completed |
NCT03156647 -
Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
|
||
Recruiting |
NCT02994719 -
Gait Analysis in Neurological Disease
|
||
Completed |
NCT04974034 -
Movement Disorders Analysis Using a Deep Learning Approach
|
||
Terminated |
NCT00686699 -
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
|
Phase 2 | |
Completed |
NCT04925622 -
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
|
||
Recruiting |
NCT06193252 -
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
|
N/A | |
Enrolling by invitation |
NCT06283043 -
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
|